ABC NewsSep 16, 2022Quote SymbolU.S. health officials are warning against overuse of the lone drug available to treat monkeypox, saying that even a small mutation in the virus could render the pills ineffective.
Knowledge Is PowerAfter COVID and monkeypox, experts say outbreaks anywhere threaten citizens everywhereABC NewsGlobal infectious disease outbreaks could become the new normal, scientists say. With the emergence of COVID-19 and the recent surge in monkeypox …
Knowledge Is PowerMinorities are bearing the brunt of monkeypox cases in the US: CDCABC NewsHispanic and Black people account for 64% of cases, but 32% of all Americans. Minorities are bearing the brunt of monkeypox cases in the United …
Knowledge Is PowerMonkeypox: What public health experts want you to knowABC NewsMore than 10,000 cases of monkeypox have been confirmed in the U.S. Since the first case of monkeypox was detected in the United States in mid-May, …
Knowledge Is PowerStoryboardHow the U.S. Botched Its Monkeypox Vaccine RolloutCurated byThe Science DeskAmericans were told at the onset of the current outbreak that the United States was prepared with vaccine doses stockpiled away. But that wasn't the case: Millions of these doses were left to expire and a failure to ramp up vaccine production has resulted in a supply shortage. People are upset at the Biden administration's seemingly sluggish response. So what happened?
Knowledge Is PowerMonkeypox is accelerating so fast the only approved vaccine maker admits it doesn’t know if it can keep up with demandverified_publisherFortune - Christian Wienberg, BloombergBavarian Nordic A/S, the only company with an approved vaccine for monkeypox, said it’s no longer certain it can meet demand as cases continue to …
